Real estate for pathologists: passive depreciation strategy

High W-2, no time, no practice equity. Here’s the syndication and short-term rental playbook for pathologists.

For many of us in pathology, the career path is a paradox. We are at the center of diagnosis, wielding increasingly sophisticated technology, yet our financial structure often mirrors that of a highly-paid employee. Unlike a surgeon who builds an ASC or a radiologist who owns an imaging center outright, many pathologists are hospital-based or part of large corporate groups. The W-2 income is high, the tax bill is higher, and the path to building equity can feel frustratingly narrow. The traditional advice—max out your 401(k) and buy some index funds—is necessary but insufficient for offsetting a 37% federal tax bracket plus state taxes.

This is where the tax code, specifically as it applies to real estate and equipment, becomes your most powerful financial instrument. The strategies that allow interventional radiologists and orthopedic surgeons to build massive wealth through practice ownership are directly applicable to pathologists, whether you’re a partner in a private group with an outpatient lab or a W-2 employee looking to shelter income. This isn’t about flipping houses. It’s about using depreciation—a non-cash “paper” expense—to legally and dramatically reduce your taxable income. For more foundational resources on practice and finance, see the full pathology hub.

The Heavy Iron Play: Section 179 and Bonus Depreciation

Pathology is a capital-intensive specialty. Digital pathology scanners, mass spectrometers, advanced molecular testing platforms—this is expensive equipment. If your group is buying it, you need to understand how the tax treatment of that purchase directly impacts your personal bottom line. The two most powerful tools here are Section 179 and bonus depreciation.

Think of it this way: when a business buys a large asset, the IRS typically requires it to be depreciated over several years. But these two provisions create a massive exception.

• Section 179 Deduction: This allows a business to treat the cost of qualifying equipment as an immediate expense in the year it’s purchased and placed in service. For 2026, the limit on this immediate deduction is $1.16 million.
• Bonus Depreciation: This kicks in for expenses above the Section 179 limit. It allows you to deduct a large percentage of the remaining cost in the first year as well. While the bonus percentage is scheduled to phase down, it remains an incredibly potent tool.

Here’s a concrete example: Your pathology group decides to build out an independent lab and purchases a new digital pathology scanning and analysis suite for $1.8 million.

• You expense the first $1.16 million immediately under Section 179.
• The remaining $640,000 is eligible for bonus depreciation.

In one year, the practice generates a $1.8 million non-cash deduction. For a four-partner group, that’s a $450,000 loss passed through to each partner on their K-1, directly offsetting their clinical income. This is how practice owners can show high cash flow but a modest taxable income.

Planning Trap to Avoid: The “placed in service” rule is absolute. You cannot claim the deduction for equipment that was delivered on December 28th but wasn’t installed, calibrated, and ready for use until January. The purchase and the operational start must occur in the same tax year. Coordinate with vendors to ensure your timeline aligns with your tax strategy, not just their sales quarter.

The QBI Workaround: Your Equipment Leasing Company

One of the most significant tax breaks from the Tax Cuts and Jobs Act was the Section 199A Qualified Business Income (QBI) deduction, which allows owners of pass-through businesses to deduct up to 20% of their business income. The problem? Physicians, including pathologists, are classified as a “Specified Service Trade or Business” (SSTB). This means the QBI deduction is phased out and eliminated for high-income earners.

However, a sophisticated structuring strategy can help you reclaim a piece of it. The solution involves creating a separate, legally distinct entity that owns the expensive lab equipment and leases it back to your pathology practice.

Here’s how it works:

1. You and your partners form a separate C-Corp or LLC—let’s call it “Pathology Equipment Co.”
2. This new company purchases the multi-million dollar digital scanner or molecular platform.
3. Pathology Equipment Co. then leases the equipment to your main pathology practice at a fair market, commercially-reasonable rate.

The key is that the equipment leasing company’s primary activity is rental, which is *not* an SSTB. The net rental income it generates (lease payments minus its own expenses like depreciation) may be eligible for the full 20% QBI deduction, even if the partners’ income is well above the SSTB phase-out threshold.

Planning Trap to Avoid: This is not a DIY project for LegalZoom. The IRS has strict aggregation rules under Treasury Regulation §1.199A-4 that govern when related entities can be grouped. You must have common ownership (typically 50% or more), and the entities must be properly maintained with real lease agreements and separate books. Using a CPA and an attorney who specialize in physician practice structures is non-negotiable. Getting this wrong can unwind the entire strategy and attract an audit.

Owning the Facility: Outpatient Center and Lab Economics

For pathologists with the opportunity to buy into an independent lab or an outpatient multispecialty center, the financial benefits extend far beyond the equipment. Owning the actual real estate or the operating entity itself turns you from an employee into an owner, with all the associated tax advantages. The primary vehicle for this is the Schedule K-1.

When you’re a partner in an LLC or partnership, you don’t get a W-2 from that entity. Instead, you receive a K-1, which reports your pro-rata share of the business’s income, gains, losses, deductions, and credits. This is where the massive “paper losses” from depreciation we’ve discussed show up.

Consider a new outpatient lab. In its first year, it might bring in $1 million in revenue and have $600,000 in operating expenses (staff, supplies, etc.), for a pre-tax profit of $400,000. But if it also bought $1.5 million in equipment, the Year 1 depreciation deduction could be the full $1.5 million. The lab’s tax return would show:

$400,000 (Operating Profit) – $1,500,000 (Depreciation) = -$1,100,000 (Net Taxable Loss)

This $1.1 million loss is passed through to the partners on their K-1s, where it can be used to offset other income, including their clinical salaries. You receive cash distributions from the profitable operations while simultaneously receiving a tax loss to shelter that income. This is the fundamental economic engine of physician-owned ancillaries. You can model out different scenarios using a real estate investing calculator to see how depreciation impacts cash-on-cash return.

Planning Trap to Avoid: The distinction between active and passive participation is critical. To deduct these business losses against your active W-2 income, you generally need to meet the IRS criteria for “material participation.” This involves specific tests, often based on the number of hours you spend working in that business per year. If you are purely a silent investor with no involvement, these losses are deemed “passive” and can only be used to offset passive income (e.g., from rental properties or other K-1s). They cannot offset your W-2 salary.

Accelerating Deductions: Cost Segregation on Your Lab or Clinic

If your partnership owns the building that houses your lab or clinic, you can supercharge your depreciation deductions with an engineering-based strategy called a cost segregation study. Normally, a commercial building is depreciated straight-line over 39 years. A $3.9 million building would generate a $100,000 depreciation deduction each year. A cost segregation study shatters that timeline.

The study involves engineers and tax specialists who analyze the components of your building and reclassify them from “real property” (39-year life) into “personal property” with much shorter depreciable lives.

• 5-Year Property: Carpeting, specialty electrical wiring for lab equipment, cabinetry, decorative lighting.
• 7-Year Property: Office furniture.
• 15-Year Property: Land improvements like parking lots, sidewalks, and landscaping.

It’s common for a cost segregation study on a medical facility to reclassify 20-30% of the building’s cost basis into these shorter-lived categories. On our $3.9 million building, that could mean moving $1 million of value from a 39-year schedule to a 5 or 7-year schedule. Better yet, this reclassified property is often eligible for bonus depreciation, allowing you to deduct a huge portion of that $1 million in Year 1.

Instead of a $100,000 deduction, your first-year depreciation on the building could be many times that, creating another massive paper loss to shelter income.

Planning Trap to Avoid: A cost segregation study must be performed by a reputable engineering firm that specializes in this work. A simple estimate by your accountant is not sufficient and will not withstand an IRS audit. The firm produces a detailed report that becomes the basis for your tax filing. The cost of the study (typically a few thousand dollars) is easily recouped by the tax savings in the first year.

Applying Cost Segregation to Your Personal Rentals

This strategy isn’t just for commercial properties. It’s arguably even more powerful when applied to personal real estate investments, like the short-term or long-term rentals you might own to diversify away from the stock market. For residential rental property, the default depreciation schedule is 27.5 years. A cost segregation study works the same way, identifying components that can be written off faster.

Let’s say you buy a single-family rental for $500,000 (excluding land value). A cost segregation study might identify $100,000 (20%) as 5-year and 15-year property. With bonus depreciation, you could potentially take a massive deduction in the first year, creating a significant “paper loss” on a property that is actually cash-flowing positively every month.

This is where it all comes together. How do you use that rental loss to offset your high W-2 income? By default, you can’t. Rental losses are passive. But there is a critical exception: achieving Real Estate Professional Status (REPS).

If you or your spouse qualifies for REPS, your rental losses become non-passive. They can be used to directly offset your active income. To qualify, a person must:

1. Spend more than 750 hours during the tax year in real property trades or businesses.
2. Spend more than 50% of their total working time on these real estate activities.

For a busy pathologist, hitting these hours is nearly impossible. But for a spouse who works part-time, stays at home, or is looking for a new venture, it’s very achievable. They manage the properties, deal with contractors, screen tenants, and keep a contemporaneous log of their hours. If they qualify and you file your taxes jointly, the six-figure “paper loss” generated by cost segregation and bonus depreciation on your rental portfolio can wipe out a huge chunk of your clinical income. This strategy alone can save high-income physicians tens or even hundreds of thousands of dollars in taxes per year. For benchmarking returns and operational costs, some investors use aggregated sources like Repit data to inform their pro-formas.

Planning Trap to Avoid: The hours log is non-negotiable. In an audit, the IRS will ask for proof of the 750+ hours. A detailed, contemporaneous log (kept in a calendar, spreadsheet, or app) showing dates, activities, and time spent is your defense. Trying to recreate it years later will not work.

The tax code is complex, but it contains specific, powerful incentives for those who invest in the equipment and real estate that form the backbone of the economy. For pathologists, whose high income often lacks the equity and tax shelters of other specialties, these strategies are not just optimizations—they are a direct path to building durable, tax-efficient wealth. It’s about shifting your mindset from just earning a high salary to actively managing your tax liability like the business owner you are.

Free GigHz Tools That Pair With This Article

Three free tools that complement the material above:

• ACR Appropriateness Criteria Lookup — Type an indication or clinical scenario in plain language and get the imaging studies the ACR rates for it, with adult and pediatric radiation levels. Built directly from 297 ACR topics, 1,336 clinical variants, and 15,823 procedure ratings.
• GigHz Imaging Protocol Library — A searchable library of 131 imaging protocols with the physics specs surfaced and the matching ACR Appropriateness Criteria alongside. Plain-English narratives readable in 60 seconds, organized by modality.
• GigHz Radiation Dose Calculator — Pick the imaging studies a patient has had and see total dose in millisieverts (mSv) with comparisons to natural background radiation, transatlantic flights, and chest X-rays. Useful for shared decision-making.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 21, 2026